PKIs | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

173 results for “PKIs”

Trials

View all 147 →

Heraeus MicroDTTect Lyon Pilot Studyprosthetic Joint Infections (PJIs)

20 participants · First posted May 1, 2020

Tyrosine Kinase Inhibitors (TKIs) in Trastuzumab Emtansine (T-DM1) Resistant HER2-positive Metastatic Breast Cancer: A Real-world Study

100 participants · First posted Feb 9, 2022

Observation of the Effect of Chemotherapy Combined With Tyrosinase Inhibitor on the Reactivation of CMV and EBV in Patients With Acute Lymphoblastic Leukemia

100 participants · First posted Nov 6, 2017

Drugs

PKSI-527

PKI-166

Investigational

PKI-179

C₂₅H₂₈N₈O₃

News

View all 19 →

FDA Sets October 2025 PDUFA Date for Xspray Pharma's Resubmitted Dasynoc Application

AI-Driven Drug Discovery Accelerates with New Academic Alliance Targeting Protein Kinases

Xspray Pharma Plans Dasynoc NDA Resubmission After Positive FDA Meeting

Page 1 of 18